Here are two new ETFs for Canadian investors

Article Excerpt

This month we feature an ETF that aims to deliver high income by using leverage and derivative instruments. The second comes from iShares and invests globally in companies that it sees as being at the forefront of electric and autonomous vehicle development. MULVIHILL U.S. HEALTHCARE ENHANCED YIELD ETF $9.79 (Toronto symbol XLVE) invests in large U.S. healthcare companies. To generate additional returns beyond their dividend yields, the fund can also use leverage by borrowing up to 25% of its asset value. The ETF intends to pay a monthly dividend supplemented by income derived from the sale of derivatives, including call options. The initial dividend target yield is 7% per year. The ETF launched in February 2023, and charges a management fee of 0.65%. The fund’s use of leverage expands risk—it boosts returns when markets are rising, but also increases investor losses when markets fall. Meanwhile, selling call options, for example, tends to diminish any capital gains that its portfolio might generate. When the stocks that the…